IMPACT OF LOW-DOSE SACUBITRIL-VALSARTAN ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION

Authors

  • Kaleemullah Sheikh Liaquat National Hospital and Medical College, Karachi, Pakistan
  • Abeer Sarfaraz Liaquat National Hospital and Medical College, Karachi, Pakistan
  • Sana Sarfaraz Department of Pharmacy and Pharmaceutical Sciences, University of Karachi, Pakistan
  • Amna Janjua Liaquat National Hospital and Medical College, Karachi, Pakistan
  • Sana Shoaib Liaquat National Hospital and Medical College, Karachi, Pakistan
  • Sanjana Devi Liaquat National Hospital and Medical College, Karachi, Pakistan

DOI:

https://doi.org/10.47144/phj.v55iSupplement1.2422

Abstract

Objectives: The present study aimed to observe the beneficial effects of sacubitril-valsartan at a lower dose of 24/26mg BID in a third-world country (Pakistan).

Methodology: This was a randomized, prospective, observational cohort study conducted at a tertiary care hospital in patients diagnosed, managed, and discharged as a case of heart failure with reduced ejection fraction and followed up in the cardiac outpatient department 6 weeks post-discharge. The required information was collected from the patients by means of a designed questionnaire containing minimal personal information, including age and gender. The questionnaire used was an FDA-approved KCCQ indicated for the use of assessing the quality-of-life change before and following the therapy indicated for HF with reduced ejection fraction. The data was analyzed using SPSS version 26.

Results: This study included a total of 77 patients out of which 49 were male (63.6%) and 28 were female (36.4%). The mean age of the patients included was 60.05± 11.80 years. 68.8% of them were hypertensive and 51.9% were diabetic. All patients included were those with reduced Ejection Fraction out of which 29.9% had EF between 20-25%, 49.3 % had it between 30-35% whereas 20.8% of patients had an EF of 40%. In the case of NYHA class before starting Sacubitril/Valsartan approximately 84.4% of patients were in class 3 and 15.6% of them belonged to class 4. The functional class was improved 6 weeks post-treatment in which 79.2% of patients had functional class 2 and 20.8% of them had class 3. The comparison between KCCQ scores of heart failure patients before treatment and after treatment with sacubitril/valsartan at the dosage of 24/26mg BID were statistically significant.

Conclusion: It was thus concluded from the study that even a low dose of sacubitril-valsartan results in improved quality of life as assessed by KCCQ scoring in patients with heart failure with reduced ejection fraction.

Downloads

Download data is not yet available.

Downloads

Published

2022-11-17

How to Cite

1.
Sheikh K, Sarfaraz A, Sarfaraz S, Janjua A, Shoaib S, Devi S. IMPACT OF LOW-DOSE SACUBITRIL-VALSARTAN ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION. Pak Heart J [Internet]. 2022Nov.17 [cited 2024Apr.20];55(Supplement1):S6. Available from: https://pakheartjournal.com/index.php/pk/article/view/2422

Issue

Vol. 55 No. Supplement1 (2022): Pakistan Heart Journal

Section

Conference Abstract

License

Copyright (c) 2022 Pakistan Heart Journal

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

When an article is accepted for publication in the print format, the author will be required to transfer exclusive copyright to the PHJ and retain the rights to use and share their published article with others. However, re-submission of the full article or any part for publication by a third party would require prior permission of the PHJ.

Online publication will allow the author to retain the copyright and share the article under the agreement described in the licensing rights with creative commons, with appropriate attribution to PHJ. Creative Commons attribution license CC BY 4.0 is applied to articles published in PHJ https://creativecommons.org/licenses/by/4.0/